SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-062716
Filing Date
2020-05-15
Accepted
2020-05-15 16:54:27
Documents
83
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 EXHIBIT 10-Q tm2014558-1_10q.htm 10-Q 1070315
2 EXHIBIT 31.1 tm2014558d1_ex31-1.htm EX-31.1 12016
3 EXHIBIT 31.2 tm2014558d1_ex31-2.htm EX-31.2 12036
4 EXHIBIT 32.1 tm2014558d1_ex32-1.htm EX-32.1 4879
5 EXHIBIT 32.2 tm2014558d1_ex32-2.htm EX-32.2 4749
  Complete submission text file 0001104659-20-062716.txt   10146455

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ibio-20200331.xml EX-101.INS 2821878
7 XBRL TAXONOMY EXTENSION SCHEMA ibio-20200331.xsd EX-101.SCH 70267
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ibio-20200331_cal.xml EX-101.CAL 51151
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ibio-20200331_def.xml EX-101.DEF 323200
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ibio-20200331_lab.xml EX-101.LAB 514475
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ibio-20200331_pre.xml EX-101.PRE 521874
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35023 | Film No.: 20886398
SIC: 2834 Pharmaceutical Preparations